182 related articles for article (PubMed ID: 28548078)
41. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus.
Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
Lupus; 2014 Mar; 23(3):327-34. PubMed ID: 24297642
[TBL] [Abstract][Full Text] [Related]
42. Predicting eventual development of lupus nephritis at the time of diagnosis of systemic lupus erythematosus.
Kwon OC; Lee JS; Ghang B; Kim YG; Lee CK; Yoo B; Hong S
Semin Arthritis Rheum; 2018 Dec; 48(3):462-466. PubMed ID: 29566965
[TBL] [Abstract][Full Text] [Related]
43. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
[TBL] [Abstract][Full Text] [Related]
44. Association of smoking with cutaneous manifestations in systemic lupus erythematosus.
Bourré-Tessier J; Peschken CA; Bernatsky S; Joseph L; Clarke AE; Fortin PR; Hitchon C; Mittoo S; Smith CD; Zummer M; Pope J; Tucker L; Hudson M; Arbillaga H; Esdaile J; Silverman E; Chédeville G; Huber AM; Belisle P; ; Pineau CA
Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1275-80. PubMed ID: 23401335
[TBL] [Abstract][Full Text] [Related]
45. Clinical manifestations of patients with Systemic Lupus Erythematosus (SLE) in Khyber Pakhtunkhwa.
Khan A; Shah MH; Nauman M; Hakim I; Shahid G; Niaz P; Sethi H; Aziz S; Arabdin M
J Pak Med Assoc; 2017 Aug; 67(8):1180-1185. PubMed ID: 28839301
[TBL] [Abstract][Full Text] [Related]
46. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
47. Clinical features of lupus myositis versus idiopathic myositis: a review of 30 cases.
Garton MJ; Isenberg DA
Br J Rheumatol; 1997 Oct; 36(10):1067-74. PubMed ID: 9374923
[TBL] [Abstract][Full Text] [Related]
48. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
[TBL] [Abstract][Full Text] [Related]
49. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
50. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
51. Mosaic Tetrasomy 9p: A Mendelian Condition Associated With Pediatric-Onset Overlap Myositis.
Frémond ML; Gitiaux C; Bonnet D; Guiddir T; Crow YJ; de Pontual L; Bader-Meunier B
Pediatrics; 2015 Aug; 136(2):e544-7. PubMed ID: 26216333
[TBL] [Abstract][Full Text] [Related]
52. Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab.
Roth DA; Thompson A; Tang Y; Hammer AE; Molta CT; Gordon D
Lupus; 2016 Apr; 25(4):346-54. PubMed ID: 26385220
[TBL] [Abstract][Full Text] [Related]
53. Hashimoto thyroiditis, anti-thyroid antibodies and systemic lupus erythematosus.
Posselt RT; Coelho VN; Skare TL
Int J Rheum Dis; 2018 Jan; 21(1):186-193. PubMed ID: 28544477
[TBL] [Abstract][Full Text] [Related]
54. Factors associated with development and mortality of pulmonary hypertension in systemic lupus erythematosus patients.
Kim JS; Kim D; Joo YB; Won S; Lee J; Shin J; Bae SC
Lupus; 2018 Oct; 27(11):1769-1777. PubMed ID: 30028258
[TBL] [Abstract][Full Text] [Related]
55. Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus.
Vordenbäumen S; Fischer-Betz R; Timm D; Sander O; Chehab G; Richter J; Bleck E; Schneider M
Lupus; 2010 Dec; 19(14):1648-53. PubMed ID: 20724351
[TBL] [Abstract][Full Text] [Related]
56. The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study.
Yang Y; Li Z; Wang L; Zhang F
Int J Rheum Dis; 2013 Apr; 16(2):173-7. PubMed ID: 23773641
[TBL] [Abstract][Full Text] [Related]
57. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
Ramos-Casals M; Campoamor MT; Chamorro A; Salvador G; Segura S; Botero JC; Yagüe J; Cervera R; Ingelmo M; Font J
Lupus; 2004; 13(10):777-83. PubMed ID: 15540510
[TBL] [Abstract][Full Text] [Related]
58. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
59. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
Su Y; Jia RL; Han L; Li ZG
Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
[TBL] [Abstract][Full Text] [Related]
60. Venous and Arterial Thrombotic Events in Systemic Lupus Erythematosus.
Hinojosa-Azaola A; Romero-Diaz J; Vargas-Ruiz AG; Nuñez-Alvarez CA; Cicero-Casarrubias A; Ocampo-Torres MC; Sanchez-Guerrero J
J Rheumatol; 2016 Mar; 43(3):576-86. PubMed ID: 26773122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
